Health Products

Scopolamine Hydrobromide Injection (2016-01-22)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
(L) 290638E01
Recalling Firm
Hospira Healthcare Corporation, a Pfizer Company
2600 Alfred-Nobel Blvd. Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation, a Pfizer Company
2600 Alfred-Nobel Blvd. Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
Scopolamine Hydrobromide InjectionSterile solution for injectionDIN 005418770.6 mg/ml

Introduction

Affected products

Scopolamine Hydrobromide Injection

Reason

Downward trend in potency during shelf life testing. Risk of potency falling below specifications before expiry date is reached

Depth of distribution

Wholesalers and hospitals across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime